Ara
Toplam kayıt 7, listelenen: 1-7
Dramatic response to catumaxomab treatment for malign ascites related to renal cell carcinoma with sarcomotoid differentiation.
(Lippincott, Williams & Wilkins, 2014)
Refractory malignant ascites (MA) is a common complication in cancer patients. Renal cell carcinoma
(RCC) is rarely present with peritoneal ascites, which is commonly associated with carcinomas of the
gastrointestinal ...
Primary adrenal lymphoma with secondary central nervous system involvement: A case report and review of the literature
(Turkish Society of Hematology, 2013)
Approximately 10%-20% of all systemic lymphomas have central nervous system (CNS) involvement, which has been correlated to a worsened prognosis. It is well known that secondary involvement of the adrenal glands may occur ...
Guillain-Barre Syndrome in a patient with primary extranodal intestinal Non-Hodgkin’s lymphoma: paraneoplastic, drug induced or coincidental?
(Galenos Yayınevi, 2014)
Neurological involvement is observed in 5%-25% of patients with lymphoma being either
the first presentation of the disease or emerging during its course. However, Guillain-Barré
syndrome is rarely reported. In this ...
Comparison of KRAS Mutation Tests in Colorectal Cancer Patients
(2011)
The KRAS pathway and studies evaluating KRAS as a prognostic marker in colorectal cancer are discussed along with advances in KRAS gene mutation testing. Highly sensitive real-time polymerase chain reaction (PCR) methods ...
A rare cause of acute abdomen: Ruptured adrenal pheochromocytoma
(Turkish Society of Gastroenterology, 2010)
Pheochromocytoma is a tumor of the chromaffin cells which secretes catecholamines and 90% of it originates from adrenal medulla. The main symptoms and signs are hypertension, tachycardia, sweating and headache. Rarely, ...
End-of-study results of Turkish gastric cancer patients from the global REGATE study
(Zerbinis Medical Publ., 2014)
Purpose: Registry of Gastric Cancer Treatment Evaluation (REGATE) study was an international, prospective study including over 10000 patients from 22 countries, designed to describe the pattern of care in gastric cancer ...
Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: A pilot study
(Spandidos Publications, 2014)
The expression of epidermal growth factor receptor (EGFR) has been linked to clinical outcome in several solid tumors. However, the clinical significance of EGFR (c-erbB1) in gastric cancer remains unclear. The present ...